LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000137 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 8, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
5,000
Total Value
$1,430,434.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO&Secretary | Common Stock | โ | Sep 3, 2026 | Sale | 300 | $283.99 | $85,195.62 | 41,214 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Sep 3, 2026 | Sale | 1,800 | $285.17 | $513,300.78 | 39,414 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Sep 3, 2026 | Sale | 2,115 | $286.36 | $605,649.07 | 37,299 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Sep 3, 2026 | Sale | 385 | $287.53 | $110,697.24 | 36,914 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Sep 3, 2026 | Sale | 400 | $288.98 | $115,591.68 | 36,514 | Direct | โ | View Details |